Skip to content

HELP

Cybin, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$10.69
+1.33%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.72
Revenue estimate
—

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$0.91
EPS estimate
-$0.84
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
-31.2%
Revenue beats (12Q)
0

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$38
PT range
$16 – $62
Analysts
3
3 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.84-$0.91Miss -8.84%—
Jun 30, 2026-$1.04-$0.96Beat 7.81%$1.3M
Feb 13, 2026-$0.53-$0.72Miss -35.85%—
Nov 13, 2025-$0.74-$1.39Miss -87.84%—
Aug 13, 2025-$0.96-$1.10Miss -14.72%—
Jun 30, 2025-$0.85-$1.44Miss -68.76%—
Nov 13, 2024-$0.98-$2.86Miss -190.85%—
Aug 8, 2024-$0.97-$0.12Beat 88.02%—
Mar 31, 2024—-$0.17——
Nov 14, 2023—-$0.05——
Aug 14, 2023—-$0.06——
Mar 31, 2023—-$0.07——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026